BREAKTHROUGH: New Formula by American Ophthalmology Academy Targets Elderly Vision Issues with Swift Recovery.
Elon Musk Invests $50 Million in Pioneering Treatment.
SATURDAY, JUNE 1, 2024

After four years of research, Dr. Barbara O'Neill andthe American Academy of Ophthalmology have introduced a groundbreaking newtreatment for age-related eye conditions: Docenin™ Presbyopia Eye Drops. A comprehensive study involving 80,000 participants hasshown that 96% of users experienced improved vision, with symptoms of cataractsand glaucoma significantly reduced or eliminated.

She has co-developed Docenin™ with the American Academy ofOphthalmology, aiming to find the ultimate solution for human eye diseasesthrough the latest technological advancements. The Docenin™presbyopia eye drops she invented have already helped over 100,000 individualsresolve their vision issues.
This study has caught the attention of not only the medicalcommunity but also high-profile individuals. Celebrities using Docenin™Presbyopia Eye Drops include famed actorGeorge Clooney, who declared his presbyopia vanished after a month of use.
Moreover, TODAY News has stated that Docenin™ Presbyopia Eye Dropscould completely replace your reading glasses.

What can Docenin™ Presbyopia Eye Drops do for you?
In general, most people begin to lose vision after age 40 and develop eye problems such as presbyopia, cataracts, and age-related macular degeneration. The solution offered by OptiviPro can help you overcome eye problems within 4-8 weeks and improve vision.
1. Presbyopia

Presbyopia is caused by the hardening of the lensof the eye over time. It makes it difficult to focus on close objects,resulting in blurry or out-of-focus vision. Docenin™ Presbyopia EyeDrops are the first and only ones approved by the FDA to treat age-relatedvision loss. If Docenin™ Presbyopia Eye Drops get into your eyes, they can temporarily reduce pupilsize, improving your eyes' ability to focus on close objects while keepingdistance vision clear. Docenin™ Presbyopia Eye Drops use patented technology to quickly adjust to the natural pH of thetear film and are both convenient and easy to use.
2. Cataracts

Most cases of cataracts occur in people over theage of 55, but they can occasionally occur in babies or be caused by injuriesor medications. Typically, cataracts occur in both eyes, although one eye maybe more severely affected than the other. The unique formula of Docenin™ Presbyopia Eye Drops can separate the cloudy parts ofthe eye lens and make the lens clear and bright.
3. Glaucoma

Glaucoma is a disease that causes loss of visiondue to the deterioration of the optic nerve. Most patients do not notice thedisease because they have no obvious symptoms. Docenin™ Presbyopia EyeDrops can help drain fluids from the eyes, reduce intraocularpressure, and restore normal function to the eyes.
4. Dry Eye

Dry eye refers to the lack of sufficient quality tears tolubricate and nourish the eye. Tears are essential for maintaining the healthof the front surface of the eye and ensuring clear vision. Docenin™Presbyopia Eye Drops can restore the normal amount of tears in the eyeand maximally reduce dryness and associated discomfort to maintain eyehealth.
5. Diabetic Retinopathy

Diabetic retinopathy is an eye disease that can cause vision lossand blindness in diabetics. It affect the blood vessels of the retina (thelight-sensitive layer of tissue at the back of the eye). Docenin™Presbyopia Eye Drops can reduce retinal swelling, narrow bloodvessels and stop leaks to restore vision.
6. Pterygium

A pterygium is a proliferative tissue (with blood vessels) thatmay originally have originated from the conjunctiva. It may remain small orgrow large enough to cover part of the cornea. When this happens, it affectsyour vision. Docenin™ Presbyopia Eye Drops can treatdiscomfort, redness, or swelling caused by a pterygium. They can alsoreduce the chances of a pterygium growing again and help your eyes heal.
Howdo Docenin™ Presbyopia Eye Drops work?
The primary function of Docenin™ is to restore the lens to its normal size, improve cellnourishment in the eye, and clear out cellular debris deposits.

Docenin™ are the first andonly FDA-approved eye drops to treat age-related vision loss. If Docenin™ Presbyopia Eye Drops get intoyour eyes, they can temporarily shrink the pupils, improving your ability tofocus on close objects while keeping distance vision clear. Docenin™ usespatented technology that allows the eye drops to quickly adapt to the naturalpH of the tear film, making use easy and comfortable. And withdisposable eye drops, it is very safe and hygienic!
